Drug
Interferons clinical trials
- studies test it
- 58
- open now
- 4
- in phase 3
- 14
- first study started
- 1990
Keep track of what changes. Save the Interferons studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
57 studies that test it; most in 2011 (7)
| Year | Studies |
|---|---|
| 1990 | 1 |
| 1995 | 1 |
| 2000 | 3 |
| 2001 | 3 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 6 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 7 |
| 2012 | 2 |
| 2013 | 5 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 2
- 25
- Phase 3
- 14
- Phase 4
- 12
- No phase
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 19 · Other 39
Merck Sharp & Dohme LLC (5) · Gilead Sciences (3) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (3) · Boehringer Ingelheim (2) · The First Hospital of Jilin University (2) · Ortho Biotech Products, L.P. (2) · M.D. Anderson Cancer Center (2) · Hoffmann-La Roche (1)
Often tested with
Tested in the same studies.
Ribavirin (21) · Imatinib (3) · Vaniprevir (2) · Fluorouracil (2) · Valopicitabine (2) · Lamivudine (2) · Telaprevir (2) · Boceprevir (2)
Studies
Open first, then newest update. How each study uses Interferons is read from its arms, and is right about nine times in ten.
Testing it · 58
- A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B DrugsRecruitingPhase 2Ausper Biopharma Co., Ltd.NCT07069569Written as Peg-IFN
- Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid LeukemiaRecruitingPhase 3Peking University People's HospitalNCT06802718Written as Interferon
- Antiviral Therapy in Infants With HBV InfectionNot yet recruitingPhase 4Beijing 302 HospitalNCT06503796Written as Interferon
- Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial CystitisNot yet recruitingPhase 2/3West China HospitalNCT05912946Written as Interferon
- A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis BCompletedPhase 2Hoffmann-La RocheNCT04225715Written as PEG-IFN
- Treatment and Natural History Study of Lymphomatoid GranulomatosisCompletedPhase 2National Cancer Institute (NCI)NCT00001379Written as Interferon
- Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic ImpairmentCompletedPhase 1Boehringer IngelheimNCT02259855Written as Pegylated interferon
- Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid PharmacotherapyCompletedPhase 4Melbourne HealthNCT01120795Written as Pegylated interferon and ribavirin
- Intravenous Interferon During Liver TransplantCompletedNot applicableWake Forest University Health SciencesNCT01192698Written as IV interferon
- A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment FailuresCompletedPhase 1/2National Institutes of Health Clinical Center (CC)NCT01185028Written as Nitazoxanide With Pegylated Interferon And Ribavirin
- The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B PatientsCompletedNot applicableThe First Hospital of Jilin UniversityNCT03546530Written as Interferon
- Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV InfectionCompletedPhase 2Gilead SciencesNCT01826981Written as Peg-IFN
- PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis CCompletedPhase 3National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00100659Written as Pegylated Interferon/ribavirin
- Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045)CompletedPhase 3Merck Sharp & Dohme LLCNCT01405560Written as peg-IFN
- Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044)CompletedPhase 3Merck Sharp & Dohme LLCNCT01405937Written as peg-IFN
- Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin ResistanceCompletedPhase 2Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsNCT00665353Written as peginterferon
- Optimized Treatment and Regression of HBV-induced Liver FibrosisCompletedPhase 4Beijing Friendship HospitalNCT01938781Written as Peg-IFN
- A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis BStatus unknownPhase 4Tongji HospitalNCT03357822Written as Pegylated interferon
- 5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung CancerCompletedPhase 2Western Regional Medical CenterNCT01658813Written as 5-Fluorouracil and Interferon
- Advanced Cervical Cancer Trial in IndiaCompletedPhase 2University of LouisvilleNCT01276730Written as Interferon, Retinoic Acid and radiation
See all 58 studies that test Interferons →
Given in every arm · 25 — Interferons is usual care beside what is tested
- Allogeneic, Antigen-Presenting, GM-CSF-secreting, SV-BR-1-GM Whole Cell-Therapeutic Vaccine and ImmunotherapyWithdrawnPhase 1Medical College of WisconsinNCT07199413Written as Interferon
- A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis BCompletedPhase 2Shanghai HEP Pharmaceutical Co., Ltd.NCT04426968Written as Pegylated Interferon
- A Study of Vaniprevir (MK-7009) in Participants With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028)CompletedPhase 2Merck Sharp & Dohme LLCNCT00943761Written as Pegylated interferon
- Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma PatientsCompletedPhase 3M.D. Anderson Cancer CenterNCT00577993Written as Interferon
- Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis BCompletedPhase 2Replicor Inc.NCT02726789Written as pegylated interferon
- Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants (MK-7009-043)CompletedPhase 3Merck Sharp & Dohme LLCNCT01370642Written as Peg-IFN
- A Study of Safety and Efficacy of Vaniprevir Administered With Pegylated-Interferon and Ribavirin in Japanese Participants With Chronic Hepatitis C Infection (7009-016)CompletedPhase 2Merck Sharp & Dohme LLCNCT00880763Written as Pegylated Interferon (peg-IFN)
- Safety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009)CompletedPhase 2Merck Sharp & Dohme LLCNCT00704405Written as Pegylated Interferon (Peg-IFN)
- Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected SubjectsCompletedPhase 2AbbVie (prior sponsor, Abbott)NCT01314261Written as Pegylated interferon (pegIFN)
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) InfectionCompletedPhase 2AbbVie (prior sponsor, Abbott)NCT00851890Written as Pegylated interferon
- Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501CompletedPhase 2Eisai Inc.NCT01355289Written as Pegylated interferon (PEG-IFN)
- Safety, Tolerability, and Antiviral Activity of ANA598 Administered in Combination With Pegylated Interferon and Ribavirin for the Treatment of Genotype-1 Chronic HCV InfectionCompletedPhase 2Hoffmann-La RocheNCT00978497Written as Peginterferon
- Comparative Effectiveness and Tolerability of Boceprevir vs TelaprevirCompletedNot applicableLouis Stokes VA Medical CenterNCT02113631Written as Peg-IFN
- Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1CompletedNot applicableNational Institute on Drug Abuse (NIDA)NCT00249574Written as pegInterferon
- Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected PatientsCompletedPhase 1Boehringer IngelheimNCT01525628Written as pegylated interferon
- This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis CCompletedPhase 2Boehringer IngelheimNCT01528735Written as peginterferon
- Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV StudiesCompletedPhase 3Gilead SciencesNCT01625338Written as Peg-IFN
- Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005)CompletedPhase 2Merck Sharp & Dohme LLCNCT01852604Written as Pegylated interferon (Peg-IFN)
- The Effect of Adding Metformin to the Treatment of Hepatitis CCompletedPhase 4Tehran University of Medical SciencesNCT00560690Written as pegylated interferon
- Viral Kinetics in HCV Clearance in Subjects With HemophiliaCompletedPhase 1Kenneth ShermanNCT01704521Written as PegInterferon
Showing 20 of 25.
As the comparator · 7 — what is tested is compared with Interferons
- Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C PatientsCompletedPhase 2NovartisNCT00759200Written as peg-interferon
- BAY43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell CarcinomaCompletedPhase 2BayerNCT00117637Written as Interferon
- Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C InfectionCompletedPhase 2GlobeImmuneNCT00606086Written as Pegylated Interferon and Ribavirin
- Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV PatientsCompletedPhase 2TransgeneNCT01055821Written as pegylated interferon and ribavirin
- A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated MelanomaStatus unknownPhase 2Peking University Cancer Hospital & InstituteNCT01782508Written as Interferon
- Pilot Trial of Bavituximab Combined With Ribavirin for Initial Treatment of Chronic HepC Virus Genotype 1 InfectionCompletedPhase 1/2Peregrine PharmaceuticalsNCT01273948Written as Pegylated interferon (PEG-IFN)
- The Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Patients With Chronic Hepatitis B Virus (HBV) InfectionStatus unknownNot applicableZiv HospitalNCT01083251Written as Peginterferon
Codes
What other systems call Interferons · ClinicalTrials.gg INT007671
- MeSH (NLM) D007372InterferonsOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D007372 | Interferons | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.